Evidence map›Paper›PMID 29600050›Full record

ArticleJournal of thoracic disease2018

Xin Wen, Jing Yan, Xin-Rui Han, Gui-Hong Zheng, Ran Tang, Li-Fang Liu, Dong-Mei Wu, Jun Lu, Yuan-Lin Zheng

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Retraction:Journal of thoracic disease · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Adiponectin and Asthma: Knowns, Unknowns and Controversies.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Airway hyperresponsiveness development and the toxicity of PM2.5.Environmental science and pollution research international · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. NeonatalBioMed research international · 2019
    Article
  15. Article
4 · The record

Corrections and comments

  • Retraction · 2022-09-01False/Forged Authorship · Falsification/Fabrication of Data · Investigation by Company/Institution · Investigation by Journal/Publisher · Misconduct - Official Investigation(s) and/or Finding(s) · Misconduct by Author · Objections by Third Party · Original Data and/or Images not Provided and/or not Available · Unreliable Results and/or Conclusions · · see also: https://pubpeer.com/publications/0ED696FA479FD5B77FCF3877C9BC65 and https://www.nsfc.gov.cn/publish/portal0/tab442/info85495.htm
  • Retracted
5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xin WenKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, China.
Jing YanEmergency Center, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221009, China.
Xin-Rui HanKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, China.
Gui-Hong ZhengKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, China.
Ran TangDepartment of Respiratory Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China.
Li-Fang LiuDepartment of Respiratory Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China.
Dong-Mei WuKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, China.
Jun LuKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, China.
Yuan-Lin ZhengKey Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, China.
Jiangsu Normal University · CNFirst Affiliated Hospital Zhejiang University · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAllergic asthma is a complex genetic disorder that involves interactions between genetic and environmental factors. Usage of PTEN may be a good therapeutic strategy for the management of allergic inflammation. Thus, the present study aims to explore the effects of phosphatase and tensin homolog (

methodsA total of 56 healthy female BABL/c mice (weighing between 16 to 22 grams) were selected and were assigned on random into ovalbumin (OVA; mice were stimulated with OVA to induce allergic asthma), OVA + si-PTEN, normal saline (NS; mice were treated with normal saline) and NS + si-PTEN groups. Masson staining was employed in order to observe lung tissue sections. Immunohistochemical staining was used to detect the expression of α-SMA

resultsAirway remodeling and changes of smooth muscle layer were found in allergic asthmatic mice with thick airway walls. The expression of alpha smooth muscle actin (α-SMA

conclusionsThese results demonstrated that PTEN gene silencing might promote proliferation of ASMCs and airway remodeling in a mouse model of allergic asthma.

Indexed as

airway remodelingairway smooth muscle cell (ASMC)alpha smooth muscle actinasthmacell proliferationgene silencingPhosphatase and tensin homolog (PTEN)

Identifiers

PMID29600050
PMCPMC5863171
OpenAlexW2783548704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.